日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway.

整合蛋白质组学和代谢组学揭示丙酸通过 RGN-PPARα 通路对酒精性肝病的直接肝脏保护作用。

Wang Haidi, Liu Haitao, Wang Miaoxin, Chi Tengjiao, Liu Fengting, Qu Xinyan, Mu Yan, Xu Qi, Wang Quanbo

Curcumin induces and enhances the PARP1-mediated parthanatos in diffuse large B cell lymphoma.

姜黄素可诱导和增强弥漫性大B细胞淋巴瘤中PARP1介导的PARP诱导的细胞死亡。

Wang Yayun, Qi Ruili, Zhao Xuanzhu, Mei Hanwei, Qiu Minghan, Liu Fengting, Wang Huaqing

The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility

核磷脂酰肌醇-p53信号复合物在细胞运动调控中的作用

Hou, Xiaoting; Chen, Yu; Zhou, Bo; Liu, Fengting; Dai, Lingyun; Chen, Chunbo; Carrillo, Noah D; Cryns, Vincent L; Anderson, Richard A; Sun, Jichao; Chen, Mo

Physical exercise and depression in university students with psychological resilience as mediator and family support as moderator

体育锻炼与大学生抑郁症的关系:以心理韧性为中介变量,家庭支持为调节变量

Yang, Fan; Gao, Yiran; Liu, Fengting

Transcriptome landscape of the adrenal gland and superior cervical ganglion from hypertension-induced left ventricular hypertrophy rat model.

高血压诱导左心室肥大大鼠模型肾上腺和颈上神经节的转录组图谱

Li Chaohong, Liu Fengting, Li Xingyu, Yang Xiaohua, Li Qiaoqiao, Huang Jing

DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy

DR30318,一种用于 Claudin 18.2 阳性癌症免疫治疗的新型三特异性 T 细胞接合剂

Zhe Ma #, Zhenxing Zhou #, Wenwen Duan, Gaofeng Yao, Shimei Sheng, Sidou Zong, Xin Zhang, Changkui Li, Yuanyuan Liu, Fengting Ou, Maha Raja Dahar, Yanshan Huang, Lushan Yu

The "outsized" role of the I-helix kink in human Cytochrome P450s

人类细胞色素P450中I螺旋扭结的“超大”作用

Zhang, Jingjing; Liu, Fengting; Suo, Yaran; Tong, Dudu; Hu, Jinyu; Lyu, Hai-Ning; Liao, Jingjing; Wang, Jiaqi; Wang, Jigang; Xu, Chengchao

ESDiff: a joint model for low-quality retinal image enhancement and vessel segmentation using a diffusion model

ESDiff:一种利用扩散模型进行低质量视网膜图像增强和血管分割的联合模型

Liu, Fengting; Huang, Wenhui

Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study

在中国,一项多中心、单臂、II期研究评估了西达米德联合利妥昔单抗治疗老年复发或难治性B细胞淋巴瘤患者的安全性。

Chen, Xinrui; Wang, Huaqing; Sun, Xiuhua; Su, Liping; Liu, Fengting; Zhao, Ke; Xu, Liye; Wu, Shaohua; Song, Teng

Involvement of NF-κB in the reversal of CYP3A down-regulation induced by sea buckthorn in BCG-induced rats

NF-κB参与逆转沙棘诱导的BCG诱导大鼠CYP3A下调

Liu, Fengting; Wang, Tao; Li, Xiaoxia; Jia, Jinxue; Lin, Qin; Xue, Yongzhi